Ansa Biotechnologies, Inc. logo

Ansa Biotechnologies, Inc.

High-fidelity DNA synthesis using enzymes

81 employees · est. 2018 · Emeryville, United States

VS
Codex DNA logo

Codex DNA

Innovative synthetic biology technologies enabling rapid, accurate DNA synthesis for academic and commercial research

5 employees · est. 2011

Codex DNA is the older company (2018 vs 2011); Ansa Biotechnologies, Inc. is the larger of the two.

Side-by-Side Comparison

Ansa Biotechnologies, Inc. Codex DNA
Founded
2018 2011 older
Headquarters
Emeryville, United States Not tracked yet
Employees
81 larger 5
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology
Funding Stage
Series B IPO
Total Funding
$136.96M $122.70M
Funding Rounds
7 2
Services
DNA Synthesis up to 50 kb, Custom Vector Design, Large Construct Synthesis, Sequencing Error Reduction, On-time Delivery Guarantee advanced RNA and DNA workflows, Gibson SOLA platform, BioXp system, custom synthetic biology solutions
Target Customers
Biotech Companies, Academic Researchers, Gene Therapy Developers, Pharmaceutical Manufacturers, Agricultural Biotechnology Firms biotech companies, pharmaceutical companies, researchers in therapeutic discovery, synthetic biology community, diagnostic developers
Taxonomy
High-fidelity DNA Synthesis, Enzymatic DNA Synthesis, Biotechnology Innovation, Gene-length Molecules, Medicine Innovation, Agricultural Biotechnology, Industrial Biotechnology, Enzyme-based Technology, Biological Research Acceleration, Sustainable Solutions, Healthcare Advancement, Biological Engineering, Synthetic Biology Synthetic Biology, DNA Synthesis, Gene Synthesis, Biotechnology Hardware, Biotechnology Software, Bioresearch Tools, Academic Research Solutions, Commercial Research Solutions, Genomics, Molecular Biology, Biotech Innovation, Research Methodologies, Life Sciences Technology, Rapid Synthesis Technologies, Genetic Engineering Tools
Website
ansabio.com codexdna.com
Ansa Biotechnologies, Inc. logo

About Ansa Biotechnologies, Inc.

Ansa Biotechnologies, Inc., founded in 2018 and headquartered in the United States, is at the forefront of biotechnological innovation. Specializing in Biotechnology, Health and Wellness, and Life Sciences, the company is renowned for its slogan: "High-fidelity DNA synthesis using enzymes." Ansa's...

Codex DNA logo

About Codex DNA

Codex DNA, founded in 2011, is a biotechnology company focused on advancing the synthetic biology market. With its slogan, "Innovative synthetic biology technologies enabling rapid, accurate DNA synthesis for academic and commercial research," the company emphasizes its commitment to facilitating ex...

We will tell you when either one moves

BounceWatch watches Ansa Biotechnologies, Inc. and Codex DNA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ansa Biotechnologies,... and Codex DNA — by email.

Frequently Asked Questions

Ansa Biotechnologies, Inc. — High-fidelity DNA synthesis using enzymes. Codex DNA — Innovative synthetic biology technologies enabling rapid, accurate DNA synthesis for academic and commercial research. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ansa Biotechnologies, Inc. has raised $136.96M while Codex DNA has raised $122.70M.
Ansa Biotechnologies, Inc. and Codex DNA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ansa Biotechnologies, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ansa Biotechnologies, Inc. on 26 Aug 2026, and Codex DNA on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy